Drugs under development to treat those affected by acute spinal cord injuries are not expected to emerge within the current decade, leaving the market largely open to new entrants, according to a new report issued by pharmaceuticals intelligence provider GlobalData.The new report, "Acute Spinal Cord more

Clearbridge BioMedics has won the 2012 Asian Entrepreneurship Awards, which was held from 9-11 May 2012 in Kashiwanoha, Chiba Prefecture in Japan. A total of 18 start-up companies, from 12 Asian countries presented their business plans at this inaugural business competition. Clearbridge BioMedics more

Rare and niche diseases are being increasingly spotlighted by pharmaceutical and biotechnology corporations in the hope of developing initial treatments or improving upon existing therapies for these conditions, according to a new report released by GlobalData.The new report, "Rare and Niche Disease more

The 2008 decision by the Centers for Medicare & Medicaid Services (CMS) to cease additional reimbursement to hospitals for certain healthcare-associated infections (HAIs) has led to enhanced focus on infection prevention and changes in practice by front-line staff, according to a national survey of more

The conversion of prescription drugs to over-the-counter (OTC) status is becoming a hit among major pharmaceutical companies in developing countries, who are eager to expand their target audience, according to a new report by healthcare intelligence company GBI Research.The new report, "Rx-to-OTC Sw more

Arguably, two of the most noteworthy advancements in medicine and technology in the last decade have been genomics research and cloud computing, according to GlobalData. These two advancements have been on separate pathways, each having little to do with the other - until now. Today, medical researc more

Generic drugs are evolving and, at the same time, being outshone by their predecessors – super-powered pharmaceuticals developed through simplified development pathways – according to a new report by GBI Research.The new report indicates that the development of “supergenerics” is creating significan more

According to a new Espicom report, The World Generic Market Report, the global markets for generic drugs will continue to grow despite cost containment pressures from health payers in many markets.  While the generic market will grow overall, distribution will vary.  Growth in the USA is the most ob more

Alzheimer’s disease (AD) is a neurodegenerative disease of the brain characterized by beta-amyloid plaques. Most patients are diagnosed late-stage in the disease or are misdiagnosed with another form of dementia. The three hallmark biomarkers for AD are neurofibrillary “tangles”, protein amyloid or more

Existing adoption rates and commercial success of launched Monoclonal Antibodies (mAbs) for therapeutics have established a strong platform for these products. Broadening the horizontal indications for existing mAbs, expanding the applications of mAbs in new therapeutic areas and developing innovati more